GH Research PLC (GHRS)

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to developing innovative psilocybin-based therapies targeting psychiatric and neurodegenerative disorders. With a robust pipeline designed to address substantial unmet needs in mental health care, GH Research leverages a highly experienced team committed to pioneering advancements in this fast-evolving sector. The company's groundbreaking initiatives position it to redefine treatment paradigms and significantly improve patient outcomes, solidifying its potential as a leader in mental health therapeutics.